Biomedical benefits of cannabinoids?

Area of Science:

• Pharmacology
• Clinical Medicine

Background:

• Cannabinoids are investigated for potential therapeutic effects including antiemetic, antispasmodic, analgesic, and appetite-stimulating properties.
• Current scientific evidence supporting these uses, except for antiemetic effects, is sparse, with many claims relying on anecdotal reports.

Purpose of the Study:

• To review clinical trials involving cannabinoids such as delta-9-tetrahydrocannabinol (THC), nabilone, and levonantradol.
• To discuss the advantages and adverse effects of cannabinoids in clinical practice.
• To evaluate the potential place of cannabinoids in modern medicine.

Main Methods:

• Review of existing clinical trials on cannabinoids.
• Analysis of data concerning therapeutic effects, advantages, and adverse effects.
• Discussion of the current evidence base for various medical indications.

Main Results:

• Cannabinoids demonstrate established efficacy as antiemetics.
• Evidence for other therapeutic indications (e.g., epilepsy, glaucoma, asthma, analgesia, antispasmodics) is largely anecdotal and requires further scientific validation.
• The mechanisms of action for most therapeutic effects remain largely unknown.

Conclusions:

• Cannabinoids may hold value as adjuncts for symptom management in conditions where standard treatments are insufficient.
• Further rigorous clinical evaluation is necessary to establish the definitive role and efficacy of cannabinoids in medicine.
• While promising, particularly for symptom control, the clinical utility of cannabinoids requires more robust scientific evidence.